| Justin Thomas Lloyd Baynham, MD | |
|
2450 12th St Se, Salem, OR 97302 | |
| (503) 371-4350 | |
| (503) 371-1124 |
| Full Name | Justin Thomas Lloyd Baynham |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 15 Years |
| Location | 2450 12th St Se, Salem, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750516928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD161869 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salem Hospital | Salem, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Consultants, Llc | 0941271886 | 4 |
News Archive
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
Researchers in the UK have assessed data from around the world to better understand the frequency and risk factors for myocarditis and pericarditis following immunization with messenger RNA (mRNA)-based vaccines designed to protect against coronavirus disease 2019 (COVID-19).
The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling more than $1 million for 11 novel investigator-initiated research projects designed to understand the causes of and find a cure for Parkinson's disease.
› Verified 5 days ago
| Entity Name | Retina Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528181674 PECOS PAC ID: 0941271886 Enrollment ID: O20040804000160 |
News Archive
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
Researchers in the UK have assessed data from around the world to better understand the frequency and risk factors for myocarditis and pericarditis following immunization with messenger RNA (mRNA)-based vaccines designed to protect against coronavirus disease 2019 (COVID-19).
The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling more than $1 million for 11 novel investigator-initiated research projects designed to understand the causes of and find a cure for Parkinson's disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Thomas Lloyd Baynham, MD 2450 12th St Se, Salem, OR 97302-2152 Ph: (503) 371-4350 | Justin Thomas Lloyd Baynham, MD 2450 12th St Se, Salem, OR 97302 Ph: (503) 371-4350 |
News Archive
A new compendium of expert recommendations on strengthening the security and resilience of U.S. citizens after mass casualty events was released this month as a supplement to the Bulletin of the American College of Surgeons.
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
Researchers in the UK have assessed data from around the world to better understand the frequency and risk factors for myocarditis and pericarditis following immunization with messenger RNA (mRNA)-based vaccines designed to protect against coronavirus disease 2019 (COVID-19).
The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling more than $1 million for 11 novel investigator-initiated research projects designed to understand the causes of and find a cure for Parkinson's disease.
› Verified 5 days ago
Andrew C Westfall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2450 12th Street Se, Salem, OR 97302 Phone: 503-371-4350 Fax: 503-371-1124 | |
Dr. Scott Michael Mcclintic, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2450 12th St Se, Salem, OR 97302 Phone: 503-371-4350 Fax: 503-371-1124 | |
Ryan W Lapour, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
Marcus Allan East, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
John G Dodd, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 655 Medical Center Dr Ne, Salem, OR 97301 Phone: 503-581-5287 Fax: 503-588-6843 | |
Dr. Chad Max Bingham, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1285 Liberty St Se, Salem, OR 97302 Phone: 503-585-2022 Fax: 503-365-3832 | |
Dr. Richard Coleman Lieurance, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400 |